Diagnosis and treatment of sexual dysfunctions in late-onset hypogonadism
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, J.W. | - |
dc.contributor.author | Moon, D.G. | - |
dc.date.accessioned | 2021-09-07T20:22:15Z | - |
dc.date.available | 2021-09-07T20:22:15Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2011 | - |
dc.identifier.issn | 2005-6737 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/114616 | - |
dc.description.abstract | Testosterone is the principal androgen in the human male. The decline of testosterone with aging was recognized to be associated with a number of symptoms and signs that reduce the quality of life and that may even have severe, debilitating consequences. Clinically, late-onset hypogonadism (LOH) is diagnosed by use of biochemical and clinical measures. Despite published guidelines and recommendations, however, uncertainty surrounds the profile of clinical symptoms as well as the biochemical threshold of diagnosis. Clinicians should be aware of these shortcomings while adhering to the guidelines. Current treatment methods are centered on restoring testosterone to mid to lower levels of young men with natural testosterone replacements. Although recent studies have highlighted possible additional benefits involving improvement of systemic disorders, the goal of treatment is to improve sexual function, while observing for adverse effects in the prostate. Overall, the problem of LOH in debilitating the quality of life and well-being is real, and by following proper guidelines with attentiveness to the results of treatment trials, testosterone replacement therapy presents a safe and effective treatment option. © The Korean Urological Association, 2011. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.subject | albumin | - |
dc.subject | follitropin | - |
dc.subject | luteinizing hormone | - |
dc.subject | phosphodiesterase V inhibitor | - |
dc.subject | sex hormone binding globulin | - |
dc.subject | testosterone | - |
dc.subject | testosterone cipionate | - |
dc.subject | testosterone enantate | - |
dc.subject | testosterone undecanoate | - |
dc.subject | aging | - |
dc.subject | article | - |
dc.subject | chemical analysis | - |
dc.subject | clinical feature | - |
dc.subject | drug safety | - |
dc.subject | erectile dysfunction | - |
dc.subject | erythrocytosis | - |
dc.subject | fluid retention | - |
dc.subject | gingiva disease | - |
dc.subject | gynecomastia | - |
dc.subject | hepatitis | - |
dc.subject | hormone substitution | - |
dc.subject | human | - |
dc.subject | hypogonadism | - |
dc.subject | late onset hypogonadism | - |
dc.subject | male | - |
dc.subject | nonhuman | - |
dc.subject | onset age | - |
dc.subject | patient monitoring | - |
dc.subject | practice guideline | - |
dc.subject | prostate | - |
dc.subject | quality of life | - |
dc.subject | sexual dysfunction | - |
dc.subject | side effect | - |
dc.subject | skin irritation | - |
dc.subject | sleep apnea syndrome | - |
dc.subject | testosterone blood level | - |
dc.title | Diagnosis and treatment of sexual dysfunctions in late-onset hypogonadism | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, J.W. | - |
dc.contributor.affiliatedAuthor | Moon, D.G. | - |
dc.identifier.doi | 10.4111/kju.2011.52.11.725 | - |
dc.identifier.scopusid | 2-s2.0-84255198445 | - |
dc.identifier.bibliographicCitation | Korean Journal of Urology, v.52, no.11, pp.725 - 735 | - |
dc.relation.isPartOf | Korean Journal of Urology | - |
dc.citation.title | Korean Journal of Urology | - |
dc.citation.volume | 52 | - |
dc.citation.number | 11 | - |
dc.citation.startPage | 725 | - |
dc.citation.endPage | 735 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001602768 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordPlus | quality of life | - |
dc.subject.keywordPlus | sexual dysfunction | - |
dc.subject.keywordPlus | side effect | - |
dc.subject.keywordPlus | skin irritation | - |
dc.subject.keywordPlus | sleep apnea syndrome | - |
dc.subject.keywordPlus | testosterone blood level | - |
dc.subject.keywordPlus | albumin | - |
dc.subject.keywordPlus | follitropin | - |
dc.subject.keywordPlus | luteinizing hormone | - |
dc.subject.keywordPlus | phosphodiesterase V inhibitor | - |
dc.subject.keywordPlus | sex hormone binding globulin | - |
dc.subject.keywordPlus | testosterone | - |
dc.subject.keywordPlus | testosterone cipionate | - |
dc.subject.keywordPlus | testosterone enantate | - |
dc.subject.keywordPlus | testosterone undecanoate | - |
dc.subject.keywordPlus | aging | - |
dc.subject.keywordPlus | article | - |
dc.subject.keywordPlus | chemical analysis | - |
dc.subject.keywordPlus | clinical feature | - |
dc.subject.keywordPlus | drug safety | - |
dc.subject.keywordPlus | erectile dysfunction | - |
dc.subject.keywordPlus | erythrocytosis | - |
dc.subject.keywordPlus | fluid retention | - |
dc.subject.keywordPlus | gingiva disease | - |
dc.subject.keywordPlus | gynecomastia | - |
dc.subject.keywordPlus | hepatitis | - |
dc.subject.keywordPlus | hormone substitution | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | hypogonadism | - |
dc.subject.keywordPlus | late onset hypogonadism | - |
dc.subject.keywordPlus | male | - |
dc.subject.keywordPlus | nonhuman | - |
dc.subject.keywordPlus | onset age | - |
dc.subject.keywordPlus | patient monitoring | - |
dc.subject.keywordPlus | practice guideline | - |
dc.subject.keywordPlus | prostate | - |
dc.subject.keywordAuthor | Erectile dysfunction | - |
dc.subject.keywordAuthor | Hormone replacement therapy | - |
dc.subject.keywordAuthor | Hypogonadism | - |
dc.subject.keywordAuthor | Libido | - |
dc.subject.keywordAuthor | Testosterone | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.